CryoLife Signs Definitive Agreement to Acquire Cardiogenesis
CryoLife, an implantable biological medical device and cardiovascular tissue processing company, agreed to acquire surgical product maker, Cardiogenesis Corp. for about $22 million.
60
Cohera Receives Approval for Surgical Adhesive Trial
Pittsburgh-based Cohera Medical has received approval to begin clinical trials on its TissuGlu surgical adhesive in Europe.